Greenland JC, Dresser K, Cutting E, Donegan R, et al. Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial. Lancet Neurol 2026;25:39-49.
PMID: 41389828